Vina2 Invest and Construction JSC (HNX:VC2)
9,200.00
-200.00 (-2.13%)
At close: Aug 4, 2025
Revance Therapeutics Market Cap
HNX:VC2 has a market cap or net worth of 660.19 billion as of August 6, 2025. Its market cap has increased by 19.81% in one year.
Market Cap
660.19B
Enterprise Value
1.36T
Revenue
1.18T
Ranking
n/a
PE Ratio
10.99
Stock Price
$9,200.00
Market Cap Chart
Since August 28, 2008, HNX:VC2's market cap has increased from 203.52B to 660.19B, an increase of 224.39%. That is a compound annual growth rate of 7.19%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 6, 2025 | 660.19B | - |
Dec 31, 2024 | 660.19B | -7.32% |
Dec 29, 2023 | 712.31B | 84.04% |
Dec 30, 2022 | 387.04B | -85.11% |
Dec 31, 2021 | 2,600.00B | 1,535.22% |
Dec 31, 2020 | 159.00B | -15.20% |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition